Tyto Care Raises $50 Million to Expand Its Telehealth Exam and Diagnosis Offering Globally

The growth round doubles the telehealth company’s total funding after serving over 100 health organizations, thousands of clinicians, and hundreds of thousands of patients in 2019

Tyto Care, the healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical examinations, announced that it has raised $50M in an oversubscribed round co-led by Insight Partners, Olive Tree Ventures, and Qualcomm Ventures LLC with participation from previous investors, bringing the company’s total funding to over $105M. The additional funding comes as Tyto Care experiences surging demand with rapid global telehealth adoption, having witnessed 3X growth in sales in 2019 alone.

The funding will allow Tyto Care to continue to expand commercialization throughout the U.S., Europe and Asia as well as to introduce new advanced product capabilities including AI and machine learning-based home diagnostics solutions and other patented technologies.

Recommended AI News: commercetools Launches Accelerator to Roll out Enterprise Commerce Initiatives Within Two Weeks

Tyto Care has experienced double-digit telehealth utilization, over 10 times higher than standard virtual care programs, which see less than 5% utilization on average. In the wake of COVID-19, hospitals and health organizations around the world are further expanding their use of Tyto Care’s telehealth solution to remotely examine quarantined patients in hospitals and isolated patients at home.

Tyto Care’s solution enables remote medical exams of the lungs, heart, throat and ears, among other exams and vitals, allowing healthcare organizations to protect providers and avoid exposure during the COVID-19 pandemic. It also enables families and the general population to receive care without entering medical facilities, preventing the spread of the virus and significantly reducing the increased burden on already overworked health organizations. To meet the skyrocketing demand, Tyto Care is currently expediting production to fulfill three times more devices than originally forecasted for the coming quarters.

“Over the past two years, Tyto Care has increased momentum faster than ever before and is playing a leading role in changing how people receive healthcare. Telehealth is heeding the call of the COVID-19 pandemic and we are proud that our unique solution is aiding health systems and consumers around the world in the fight against the virus,” said Dedi Gilad, Co-Founder and CEO of Tyto Care. “This new funding comes at a pivotal moment in the evolution of telehealth and will enable us to continue to transform the global healthcare industry with the best virtual care solutions. We look forward to further expanding the reach of telehealth and introducing new solutions as demand for remote care continues to soar.”

Recommended AI News: BullGuard Makes Its Small Office Security Platform Freely Available to Support Small Businesses

“The on-demand era has finally reached healthcare,” said Jeff Horing, co-founder and Managing Director at Insight Partners. “Adoption of telehealth is at an all-time high and as the only solution on the market with diagnostic capabilities that can deliver clinic-quality remote care, Tyto Care is significantly disrupting the health ecosystem. As a partner that empowers fast-growing ScaleUp software companies transforming daily life, we are excited to work with Tyto Care to help usher in the next generation of healthcare.”

“Olive Tree Ventures, a digital health fund, is ecstatic to partner with Tyto Care to accelerate the adoption of global telehealth solutions. We experienced first-hand the value of Tyto Care’s solution in the Israeli market. As digital health investors, we strongly believe in the promise of telehealth and are excited to collaborate with the visionary management at Tyto Care,” said Amir Lahat, General Partner, Olive Tree Ventures.

Tyto Care witnessed threefold growth in 2019 and is working with hundreds of hospitals and over 100 health organizations including health systems, payers and strategic partners, primarily in North America, Europe and Israel. The company served hundreds of thousands of patients and performed over 200,000 telehealth exams in 2019 alone, a testament to the growing adoption of its virtual medical exam solution as an efficient, convenient and high-quality means of delivering primary care.